Integrity Implants d/b/a Accelus and CHP Merger today announced a definitive business combination agreement that gives the merged companies an enterprise value of $482 million.
If approved, the business combination is expected to be completed in early 2022.
Funding will come from $300 million held in the SPAC’s trust, as well as $414 million in Acdelus rollover equity, according to a slide deck filed today (p. 34) in an 8-K.
Based in Palm Beach Gardens, Florida, and established through the combination of Integrity Implants Inc. and Fusion Robotics, LLC, Accelus is a commercial stage medical technology company with a mission to accelerate the adoption of minimally invasive surgery. Read more.
